Does hepatic vagus nerve modulate the progression of biliary fibrosis in rats?

Autonomic Neuroscience: Basic and Clinical

Volumn 185, Issue , 2014, Pages 67-75

  Hajiasgharzadeh, Khalil ^a   Tavangar, Seyed Mohammad ^b   Javan, Mohammad ^a   Dehpour, Ahmad R ^c   Mani, Ali R ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cirrhosis; Fibrosis; Inflammation; Vagus nerve; 7 nicotinic acetylcholine receptor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BUNGAROTOXIN RECEPTOR; HYDROXYPROLINE; LIVER ENZYME; MESSENGER RNA; METHYLLYCACONITINE; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; ACONITINE; CCL2 PROTEIN, RAT; NICOTINIC RECEPTOR BLOCKING AGENT; TISSUE INHIBITOR OF METALLOPROTEINASE-1 PROTEIN, RAT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RETRIEVAL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BILIARY CIRRHOSIS; BILIARY FIBROSIS; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FIBROSIS; HEPATIC VAGUS NERVE; HYPERBILIRUBINEMIA; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CIRRHOSIS; MALE; MYOFIBROBLAST; NERVE CELL; NEUROMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VAGOTOMY; VAGUS NERVE; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DISEASE MODEL; DRUG EFFECTS; EPITHELIUM; LIVER; LIVER CIRRHOSIS, BILIARY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACONITINE; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; ASPARTATE AMINOTRANSFERASES; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIUM; HEPATOCYTES; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MYOFIBROBLASTS; NICOTINIC ANTAGONISTS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VAGOTOMY; VAGUS NERVE;

EID: 84908071329     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2014.07.005     Document Type: Article

References (42)

1. Ackerman Z., Karmeli F., Amir G., Rachmilewitz D. Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats. J. Hepatol. 1996, 24:478-486. 10.1016/S0168-8278(96)80169-3.
2. Akiyoshi H. Ultrastructure of cholinergic innervation in the cirrhotic liver in guinea pigs. Neurohistochemical and ultrastructural study. Virchows Arch. B. Cell Pathol. Incl. Mol. Pathol. 1989, 57:81-90. 10.1007/BF02899068.
3. Akiyoshi H., Terada T. Mast cell, myofibroblast and nerve terminal complexes in carbon tetrachloride-induced cirrhotic rat livers. J. Hepatol. 1998, 29:112-119. 10.1016/S0168-8278(98)80185-2.
4. Bioulac-Sage P., Lafon M.E., Saric J., Balabaud C. Nerves and perisinusoidal cells in human liver. J. Hepatol. 1990, 10:105-112. 10.1016/0168-8278(90)90080-B.
5. Bockx I., Verdrengh K., Vander Elst I., van Pelt J., Nevens F., Laleman W., Cassiman D. High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats. Gut 2012, 61:604-612. 10.1136/gutjnl-2011-301396.
6. Campbell S.J., Anthony D.C., Oakley F., Carlsen H., Elsharkawy A.M., Blomhoff R., Mann D.A. Hepatic nuclear factor kappa B regulates neutrophil recruitment to the injured brain. J. Neuropathol. Exp. Neurol. 2008, 67:223-230. 10.1097/NEN.0b013e3181654957.
7. Corbin K., Zeisel S. Choline metabolism provides novel insights into non-alcoholic fatty liver disease and its progression. Curr. Opin. Gastroenterol. 2012, 28:159-165. 10.1097/MOG.0b013e32834e7b4b.
8. Ebrahimkhani M.R., Kiani S., Oakley F., Kendall T., Shariftabrizi A., Tavangar S.M., Moezi L., Payabvash S., Karoon A., Hoseininik H., Mann D.A., Moore K.P., Mani A.R., Dehpour A.R. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut 2006, 55:1606-1616. 10.1136/gut.2005.076778.
9. Ebrahimkhani M.R., Elsharkawy A.M., Mann D.A. Wound healing and local neuroendocrine regulation in the injured liver. Expert Rev. Mol. Med. 2008, 10:e11. 10.1017/S146239940800063X.
10. Gergalova G., Lykhmus O., Kalashnyk O., Koval L., Chernyshov V., Kryukova E., Tsetlin V., Komisarenko S., Skok M. Mitochondria express α7 nicotinic acetylcholine receptors to regulate Ca2+ accumulation and cytochrome c release: study on isolated mitochondria. PLoS One 2012, 7:e31361. 10.1371/journal.pone.0031361.
11. Haddadian Z., Eftekhari G., Mazloom R., Jazaeri F., Dehpour A.R., Mani A.R. Effect of endotoxin on heart rate dynamics in rats with cirrhosis. Auton. Neurosci. 2013, 177:104-113. 10.1016/j.autneu.2013.02.022.
12. Hamdy N., El-Demerdash E. New therapeutic aspect for carvedilol: antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage. Toxicol. Appl. Pharmacol. 2012, 261:292-299. 10.1016/j.taap.2012.04.012.
13. Hayes M., Kanoski S. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:1479-1485. 10.1152/ajpregu.00356.2011.
14. Hiramoto T., Chida Y., Sonoda J., Yoshihara K., Sudo N., Kubo C. The hepatic vagus nerve attenuates Fas-induced apoptosis in the mouse liver via alpha7 nicotinic acetylcholine receptor. Gastroenterology 2008, 134:2122-2131. 10.1053/j.gastro.2008.03.005.
15. Holzhütter H.-G., Drasdo D., Preusser T., Lippert J., Henney A.M. The virtual liver: a multidisciplinary, multilevel challenge for systems biology. Wiley Interdiscip. Rev. Syst. Biol. Med. 2012, 4:221-235. 10.1002/wsbm.1158.
16. Iredale J.P., Benyon R.C., Pickering J., McCullen M., Northrop M., Pawley S., Hovell C., Arthur M.J. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J. Clin. Invest. 1998, 102:538-549. 10.1172/JCI1018.
17. Jensen K., Afroze S., Ueno Y., Rahal K., Frenzel A., Sterling M., Guerrier M., Nizamutdinov D., Dostal D.E., Meng F., Glaser S.S. Chronic nicotine exposure stimulates biliary growth and fibrosis in normal rats. Dig. Liver Dis. 2013, 45:754-761. 10.1016/j.dld.2013.02.023.
18. Khurana S., Shah N., Cheng K., Shiu B., Samimi R., Belo A., Shant J., Drachenberg C., Raufman J. Scopolamine treatment and muscarinic receptor subtype-3 gene ablation augment azoxymethane-induced murine liver injury. J. Pharmacol. Exp. Ther. 2010, 333:639-649. 10.1124/jpet.109.165118.Acetylcholine.
19. Kiba T., Saito S., Numata K., Kon Y., Mizutani T., Sekihara H. Expression of apoptosis on rat liver by hepatic vagus hyperactivity after ventromedial hypothalamic lesioning. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280:G958-G967.
20. Koshy A., De Gottardi A., Ledermann M., Saegesser H., Shaw S.G., Zimmermann A., Reichen J. Endothelial nitric oxide synthase is not essential for the development of fibrosis and portal hypertension in bile duct ligated mice. Liver Int. 2005, 25:1044-1052. 10.1111/j.1478-3231.2005.01146.x.
21. Lam H.-B., Yeh C.-H., Cheng K.-C., Hsu C.-T., Cheng J.-T. Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats. Neurosci. Lett. 2008, 438:90-95. 10.1016/j.neulet.2008.04.048.
22. Lautt W. Afferent and efferent neural roles in liver function. Prog. Neurobiol. 1983, 21:323-348.
23. Lu Y., Ward S.C., Cederbaum A.I. Nicotine enhances ethanol-induced fat accumulation and collagen deposition but not inflammation in mouse liver. Alcohol 2013, 47:353-357. 10.1016/j.alcohol.2013.04.004.
24. Mani A.R., Ippolito S., Ollosson R., Moore K.P. Nitration of cardiac proteins is associated with abnormal cardiac chronotropic responses in rats with biliary cirrhosis. Hepatology 2006, 43:847-856. 10.1002/hep.21115.
25. Mani A.R., Montagnese S., Jackson C.D., Jenkins C.W., Head I.M., Stephens R.C., Moore K.P., Morgan M.Y. Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G330-G338. 10.1152/ajpgi.90488.2008.
26. Marra F., DeFranco R., Grappone C., Milani S., Pastacaldi S., Pinzani M., Romanelli R.G., Laffi G., Gentilini P. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am. J. Pathol. 1998, 152:423-430.
27. Martelli D., McKinley M.J., McAllen R.M. The cholinergic anti-inflammatory pathway: a critical review. Auton. Neurosci 2013, 10.1016/j.autneu.2013.12.007.
28. Matteoli G., Gomez-Pinilla P.J., Nemethova A., Di Giovangiulio M., Cailotto C., van Bree S.H., Michel K., Tracey K.J., Schemann M., Boesmans W., Vanden Berghe P., Boeckxstaens G.E. A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. Gut 2013, 1-11. 10.1136/gutjnl-2013-304676.
29. Mazloom R., Eftekhari G., Rahimi M., Khori V., Hajizadeh S., Dehpour A.R., Mani A.R. The role of α7 nicotinic acetylcholine receptor in modulation of heart rate dynamics in endotoxemic rats. PLoS One 2013, 8:e82251. 10.1371/journal.pone.0082251.
30. McCuskey R.S. Anatomy of efferent hepatic nerves. Anat. Rec. A: Discov. Mol. Cell. Evol. Biol. 2004, 280:821-826. 10.1002/ar.a.20087.
31. Park J., Kang J.-W., Lee S.-M. Activation of the cholinergic anti-inflammatory pathway by nicotine attenuates hepatic ischemia/reperfusion injury via heme oxygenase-1 induction. Eur. J. Pharmacol. 2013, 707:61-70. 10.1016/j.ejphar.2013.03.026.
32. Rosas-Ballina M., Olofsson P.S., Ochani M., Valdés-Ferrer S.I., Levine Y.A., Reardon C., Tusche M.W., Pavlov V.A., Andersson U., Chavan S., Mak T.W., Tracey K.J. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 2011, 334:98-101. 10.1126/science.1209985.
33. 11C]CHIBA-1001 in humans. Nucl. Med. Biol. 2011, 38:443-448.
34. Smith R.A.J., Porteous C.M., Gane A.M., Murphy M.P. Delivery of bioactive molecules to mitochondria in vivo. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5407-5412. 10.1073/pnas.0931245100.
35. Soeda J., Morgan M., McKee C., Mouralidarane A., Lin C., Roskams T., Oben J.A. Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells. Biochem. Biophys. Res. Commun. 2012, 417:17-22. 10.1016/j.bbrc.2011.10.151.
36. Tracey K. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 2007, 117:289-296. 10.1172/JCI30555.
37. Ueki M., Koda M., Yamamoto S., Matsunaga Y., Murawaki Y. Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats. J. Gastroenterol. 2006, 41:996-1004. 10.1007/s00535-006-1891-1.
38. Ungváry G., Donáth T. Neurohistochemical changes in the liver of guinea pigs following ligation of the common bile duct. Exp. Mol. Pathol. 1975, 22:29-34.
39. Vatamaniuk M., Horyn O., Vatamaniuk O., Doliba N. Acetylcholine affects rat liver metabolism via type 3 muscarinic receptors in hepatocytes. Life Sci. 2003, 72:1871-1882. 10.1016/S0024-3205(02)02506-7.
40. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388. 10.1038/nature01339.
41. Wessler I., Kirkpatrick C.J. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br. J. Pharmacol. 2008, 154:1558-1571. 10.1038/bjp.2008.185.
42. Whitehead T.P., Robinson D., Allaway S.L. The effects of cigarette smoking and alcohol consumption on serum liver enzyme activities: a dose-related study in men. Ann. Clin. Biochem. 1996, 33(Pt 6):530-535.